WW+E Partners Secure Complete Dismissal of Securities Fraud Class Action

wwe Decisions, Homepage news, News, News

WASHINGTON – The WW+E Team, led by Founding Partners Brant Bishop and Beth Wilkinson and partner Kosta Stojilkovic, won complete dismissal of a securities fraud class action case in the Eastern District of Virginia for client MAXIMUS Inc.  In August 2017, MAXIMUS was sued under sections 10(b) and 20(a) of the Securities Exchange Act of 1934, based on allegations that the company, along with several members of its executive team, had made false or misleading statements on earnings calls and in SEC filings concerning MAXIMUS’s performance on a major contract with the British government. Led by Brant Bishop, WW+E moved to dismiss the amended complaint with prejudice, arguing that plaintiffs failed to plead facts giving rise to an inference that MAXIMUS acted with scienter, or an intent to defraud.  WW+E also argued that plaintiff failed to plead materiality as to certain alleged misstatements or omissions, and also failed to plead …

Wilkinson Walsh Secures Another Trial Victory for Bayer in Xarelto Trial

wwe Homepage news, News

Alexandra Walsh, co-founding partner of Wilkinson, Walsh + Eskovitz, Tamarra Matthews Johnson, and Rakesh Kilaru led the defense team to another victory. WASHINGTON – The Wilkinson Walsh + Eskovitz trial team, led by Founding Partner Alexandra Walsh and partners Tamarra Matthews Johnson and Rakesh Kilaru, won the third state-court bellwether trial over the blood- thinner Xarelto in the Pennsylvania Court of Common Pleas. This is the third win for Bayer in state court, and the sixth win overall, in the Xarelto litigation. The Plaintiff, Kevin Cooney, alleged that Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals were liable for claims that the Xarelto label did not adequately warn or instruct doctors on the risks of bleeding associated with the anticoagulant medicine Xarelto. Walsh and Johnson served as lead trial counsel for Bayer, and Kilaru helped direct the legal strategy. A 12-member jury in Philadelphia returned a defense verdict after less …